With support from the government of Ontario, Piramal Pharma is investing $5,314,000 to upgrade site infrastructure at their ...

Japan’s Chugai Pharmaceutical and InxMed (Hong Kong) have entered into a worldwide license agreement regarding SPYK04, a ...

Telix recently completed enrollment in the Phase 3 BiPASS study of its proprietary 68Ga-PSMA-PET agents, Illuccix® and Gozellix® for pre-biopsy prostate cancer diagnosis. The ompany has positively ...

BioSpectrum Asia, October 2026. From symptom control to disease modification: can precision biology, new modalities and blood-brain barrier technologies turn neurology's breakthroughs into a ...

The Faculty of Computer and Mathematical Sciences (FCMS) of The Hong Kong Polytechnic University (PolyU) and the Institute of ...

Researchers from the National University of Singapore (NUS) have developed a next-generation electronic skin that can both ...

Singapore’s PRECISE has been designated GA4GH’s first Regional Hub Institution for Asia Pacific and has signed agreements ...

United Immunity, a clinical stage biotechnology company, has raised a total of ¥2.2 billion in private financing, comprising ...

A new Digestive Health Centre has opened at the Woodlands Hospital in Singapore. The Centre brings together comprehensive ...

Thermo Fisher Scientific has announced the launch of Gibco™ CHO-K1 Catalog Panel, a cGMP-ready portfolio of basal and feed ...

Viome Life Sciences has signed a Memorandum of Understanding (MoU) with Druk Holding & Investments Ltd (DHI), the investment arm of the Royal Government of Bhutan, and Gelephu Mindfulness City (GMC), ...

Grünenthal, a global leader in pain management and research, and DKSH Business Unit Healthcare, a strategic healthcare business partner and leading provider of Market Expansion Services for ...